Stock APM APTORUM GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aptorum Group Limited

Equities

APM

KYG6096M1226

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 02:00:00 04/05/2024 am IST 		5-day change 1st Jan Change
5.58 USD +3.14% Intraday chart for Aptorum Group Limited +5.68% +127.89%
30/04 Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
06/03 Top Midday Gainers MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 439.8 460.2 84.01 53.44 19.64 12.69
Enterprise Value (EV) 1 437.1 460.4 54.82 45.29 24.51 10.91
P/E ratio -28.6 x -24.6 x 12.4 x -2.1 x -2 x -3.92 x
Yield - - - - - -
Capitalization / Revenue 1,147 x 860 x 92.2 x 34.7 x 15.2 x 29.4 x
EV / Revenue 1,140 x 860 x 60.1 x 29.4 x 18.9 x 25.3 x
EV / EBITDA -45.2 x -27.2 x -2.97 x -2.51 x -1.5 x -1.14 x
EV / FCF -16.1 x 162 x -6.06 x -4.09 x -3.48 x -2.08 x
FCF Yield -6.19% 0.62% -16.5% -24.4% -28.7% -48.1%
Price to Book 13.3 x 28.1 x 2.01 x 2.26 x 1.25 x 0.51 x
Nbr of stocks (in thousands) 2,898 2,904 3,401 3,563 3,571 5,182
Reference price 2 151.8 158.5 24.70 15.00 5.501 2.449
Announcement Date 15/04/19 29/04/20 19/04/21 29/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.3834 0.5352 0.9115 1.542 1.296 0.4314
EBITDA 1 -9.665 -16.9 -18.43 -18.02 -16.3 -9.599
EBIT 1 -10.33 -18.2 -19.69 -19.21 -17.51 -10.72
Operating Margin -2,693.47% -3,400.52% -2,160.69% -1,245.77% -1,351.13% -2,486.04%
Earnings before Tax (EBT) 1 -15.13 -20.12 4.92 -27.11 -11.53 -4.341
Net income 1 -14.83 -18.69 7.067 -25.05 -9.8 -2.825
Net margin -3,867.97% -3,491.77% 775.29% -1,624.64% -756.2% -654.8%
EPS 2 -5.314 -6.442 2.000 -7.150 -2.750 -0.6248
Free Cash Flow 1 -27.08 2.835 -9.047 -11.07 -7.042 -5.25
FCF margin -7,061.55% 529.67% -992.53% -718.15% -543.44% -1,217.05%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 15/04/19 29/04/20 19/04/21 29/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.22 - - 4.87 -
Net Cash position 1 2.73 - 29.2 8.15 - 1.78
Leverage (Debt/EBITDA) - -0.0132 x - - -0.2987 x -
Free Cash Flow 1 -27.1 2.83 -9.05 -11.1 -7.04 -5.25
ROE (net income / shareholders' equity) -48.1% -84.5% 18.6% -97.4% -91% -37.4%
ROA (Net income/ Total Assets) -16.8% -33% -36.1% -36.3% -51.2% -32.3%
Assets 1 88.04 56.7 -19.57 69 19.15 8.746
Book Value Per Share 2 11.40 5.630 12.30 6.620 4.400 4.790
Cash Flow per Share 2 4.140 1.790 1.030 2.280 0.5300 0.3900
Capex 1 5.65 0.84 0.16 0.13 0.19 0
Capex / Sales 1,472.55% 156.41% 17.7% 8.55% 14.42% 0.7%
Announcement Date 15/04/19 29/04/20 19/04/21 29/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
APTORUM GROUP LIMITED Stock Aptorum Group Limited
+127.89% 30.53M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. APM Stock
  4. Financials Aptorum Group Limited